All lobbying filings

WILEY REIN LLP

Lobbying for FRESENIUS KABI USA LLC · Pharmaceutical manufacturing

Filing · LD-1 registration Registration

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 14, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Illinois

Official filing document

Lobbying activity 1

Pharmacy

H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act; H.R. 6485/S. 43, Skinny Labels, Big Savings Act; Biosimilar industry issues

Bills named in this filing 4

H.R. 3269
ETHIC Act
S. 2276
ETHIC Act
H.R. 6485
Skinny Labels, Big Savings Act
S. 43
Skinny Labels, Big Savings Act

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

FRESENIUS KABI SWISSBIOSIM GMBH

Switzerland · CH - 1262 Eysins · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.